Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Policy & Advocacy
    • Health Equity
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in Trial
    • Volunteer
    • Events
    • Resources
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
    • 7 Principles
Login
  • Donate
0

Research Papers

The Effects of MDMA-Assisted Therapy on Alcohol and Substance Use in a Phase 3 Trial for Treatment of Severe PTSD

Highlights A randomized, placebo-controlled, Phase 3 trial demonstrated the safety and efficacy of MDMA-assisted therapy for the treatment of severe posttraumatic stress disorder (PTSD) Participants met …
February 11, 2022

MAPS’ Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD

The highly statistically significant results and excellent safety record suggest MDMA-assisted therapy will be approved as effective treatment for severe, chronic PTSD in 2023. 67% of participants who …
May 3, 2021

First Controlled Trial of Cannabis for the Treatment of PTSD Raises No Safety Concerns, Further Research is Needed to Determine Efficacy

Widespread anecdotal reports of benefit have led to self-treatment of the symptoms of PTSD with cannabis among Veterans and others; the safety and potential efficacy of such treatments have not previously …
March 17, 2021

MAPS-Sponsored Pilot Study: MDMA-Assisted Therapy for PTSD in Couples May Reduce PTSD Symptoms, Improve Couples’ Happiness

FOR IMMEDIATE RELEASEDecember 7, 2020 Cognitive-behavioral conjoint therapy (CBCT) for posttraumatic stress disorder (PTSD), when combined with MDMA, resulted in significant improvements in PTSD symptoms …
December 7, 2020

Study: MDMA-Assisted Therapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness

Pilot study explored the application of MDMA-assisted psychotherapy in 18 individuals experiencing moderate to severe anxiety following diagnosis with a life-threatening illness. The primary outcome, change …
November 24, 2020

Study: MDMA-Assisted Therapy Will Be Cost-Effective in the Treatment of PTSD

A peer-reviewed study published today in the research journal PLOS ONE demonstrates that MDMA-assisted psychotherapy is cost-effective in the treatment of posttraumatic stress disorder (PTSD). It is estimated …
October 14, 2020

MDMA-Assisted Therapy May Have Lasting Benefits for PTSD, Results Published in Psychopharmacology

Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the publication of the long-term follow-up results of six Phase 2 clinical trials of MDMA-assisted psychotherapy …
June 10, 2020

Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD

PRESS RELEASE: Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD CONTACT: Betty Aldworth, Director of Communications and Events, MAPS Media Requests: …
May 7, 2019

MDMA-Assisted Therapy Shows Promise for Reducing Social Anxiety in Autistic Adults, New Study Shows

PRESS RELEASE: MDMA-Assisted Therapy Shows Promise for Reducing Social Anxiety in Autistic Adults, New Study Shows Results published in Psychopharmacology CONTACT: Brad Burge, Director of Strategic Communications, …
September 18, 2018

MDMA-Assisted Therapy Shows Promise for Veterans with Chronic, Treatment-Resistant PTSD

PRESS RELEASE: MDMA-Assisted Therapy Shows Promise for Veterans with Chronic, Treatment-Resistant PTSD • Results published in The Lancet Psychiatry CONTACT: Brad Burge, Director of Strategic Communications, …
May 1, 2018

Two New Studies Show Ibogaine’s Promise As Treatment for Opioid Addiction

Observational research published in American Journal of Drug and Alcohol Abuse CONTACT:Brad Burge, Director of Communications and Marketing, MAPSMedia Requests:Press Resources: Ismail Ali, Policy Fellow, …
June 7, 2017

Social Anxiety in Autistic Adults: Article Published in Peer-Reviewed Scientific Journal

On March 25, 2015, a paper presenting the rationale for our ongoing study of MDMA-assisted therapy for the treatment of social anxiety in autistic adults was published in the peer-reviewed journal Progress …
March 25, 2015

Posts navigation

Page 1 Page 2 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Health Equity
    • Policy & Advocacy
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up



  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Proudly powered by WordPress. Hosted by Pressable.